Ryan Allway December 28th, 2021 App, Exclusive, News, Top Story Europe is the second-largest CBD market in the world after North America, with over 500 million potential customers. According to Brightfield Group, the European CBD market will grow from €270 million in 2018 to €1.4 billion by 2023, representing... Read more
Ryan Allway December 8th, 2021 App, Exclusive, News, Top Story Countries worldwide are adopting tobacco harm reduction policies to reduce smoking-related deaths and diseases. While smoking prevention and cessation are the centerpieces of these strategies, scientists believe that public health outcomes among smokers could significantly improve if they switch... Read more
Ryan Allway December 3rd, 2021 App, Exclusive, News, Top Story Canada’s legal cannabis industry is flooded with products that prioritize profits over quality. While many consumers are price-sensitive, Deloitte Canada found that 86% of Millennial and Gen Z consumers are willing to buy premium products. These trends mirror many... Read more
Ryan Allway October 15th, 2021 App, Exclusive, News, Top Story Cannabis-based pharmaceutical drug products remain a niche market despite the plant’s significant promise. By acting on the endocannabinoid system, a widespread neuromodulator that plays an important role in everything from central nervous system development to synaptic plasticity, cannabinoids have... Read more
Ryan Allway September 24th, 2021 App, Exclusive, Psychedelics, Top Story Post-traumatic stress disorder, or PTSD, is a common mental illness among veterans. According to the Department of Veteran Affairs, 11% to 30% of veterans who served in foreign wars experience PTSD, far higher than the estimated 6% of the... Read more
Ryan Allway September 14th, 2021 App, Exclusive, News, Top Story The cannabis industry is quickly evolving from dried cannabis to beverages and other product formats. At the same time, the pharmaceutical industry is increasingly embracing cannabinoids for their potential therapeutic benefits. The challenge is converting raw plant material into... Read more
Robin Lefferts August 30th, 2021 App, Exclusive, News, Top Story In order for cannabis medicine to make the big leap to mainstream acceptance, a few things likely have to take place. Doctors, not just cannabis providers, need to become more comfortable discussing and prescribing the plant. Regulations need to... Read more
Ryan Allway August 20th, 2021 App, Exclusive, News, Top Story Nature is the lifeblood of the health and wellness industry. In fact, rainforest plants account for the raw material to produce a quarter of Western pharmaceuticals, including more than 120 different drugs. The challenge is understanding natural compounds and... Read more
Ryan Allway August 17th, 2021 App, Psychedelics, Top Story Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Silo Pharma Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the therapeutic potential of psychedelics, recently announced that the U.S.... Read more
Robin Lefferts July 15th, 2021 App, Exclusive, News, Top Story In the Canadian cannabis market, Cannabis 3.0 is finally starting to realize the sales potential many investors imagined back in 2019. That is when Canada legalized cannabis-derived products like oils, extracts, and edibles, and the thought was these new... Read more